检索结果 - Gary Barnette

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene

    Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene 由 Samir S. Taneja, Ronald Morton, Gary Barnette, Paul Sieber, Michael L. Hancock, Mitchell S. Steiner

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study

    Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study 由 Matthew R. Smith, S. Bruce Malkowicz, Franklin Chu, John B. Forrest, Paul Sieber, K. Gary Barnette, Domingo Rodriquez, Mitchell S. Steiner

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

    Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer 由 Matthew Smith, Ronald A. Morton, K. Gary Barnette, Paul Sieber, S. Bruce Malkowicz, Domingo Rodriguez, Michael L. Hancock, Mitchell S. Steiner

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial

    The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐bli... 由 James T. Dalton, K. Gary Barnette, Casey E. Bohl, Michael L. Hancock, Domingo Rodriguez, Shontelle Dodson, Ronald A. Morton, Mitchell S. Steiner

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study

    Toremifene Increases Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase 3 Clinical Study 由 Matthew R. Smith, S. Bruce Malkowicz, Franklin Chu, John B. Forrest, David T. Price, Paul Sieber, K. Gary Barnette, D. Rodriguez, M. S. Steiner

    出版 2007
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor–targeting Agent

    A Phase Ib/II Study of Sabizabulin, a Novel Oral Cytoskeleton Disruptor, in Men with Metastatic Castration-resistant Prostate Cancer with Progression on an Androgen Receptor–target... 由 Mark C. Markowski, Ronald Tutrone, Christopher Pieczonka, K. Gary Barnette, Robert H. Getzenberg, Domingo Rodriguez, Mitchell S. Steiner, Daniel R. Saltzstein, Mario A. Eisenberger, Emmanuel S. Antonarakis

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    LB1530. Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen

    LB1530. Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen 由 Tara L Gonzales, Paula Skarda, Thomas G. Bird, Michael Schnaus, Mitchell S. Steiner, Alan Skolnick, K. Gary Barnette, Michael S. Gordon, Eduardo Sprinz, Domingo Rodrı́guez, Domingo Rodrı́guez, Petar Kalaydzhiev, Georgi Arabadzhiev

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: